エピソード

  • S2 Ep18: ‘A Hairtoric Moment’: Advocating for ICD-10 Codes in Scarring Alopecia
    2024/12/17
    Itisha S. Jefferson, a medical student, patient advocate, and one of the co-founders of the Scarring Alopecia Foundation's medical student program, shares the inspiring advocacy journey and team effort behind the approval of ICD-10 codes for scarring alopecias.
    続きを読む 一部表示
    29 分
  • S2 Ep17: Intervening in AD Progression for Pediatric Patients
    2024/08/02
    We recently caught up with Peter Lio, MD, a clinical assistant professor of dermatology and pediatrics at Northwestern University Feinberg School of Medicine, at the 2024 Society for Pediatric Dermatology Annual Meeting. Lio presented a session on changing the disease course in pediatric atopic dermatitis, alongside Amy Paller, MD. We'll dive into the highlights of their talk, the role of disease progression, and the exciting pipeline ahead.
    続きを読む 一部表示
    3 分
  • S2 Ep16: Food Fight - Drs Treat and Oza Debate Eczema Triggers
    2024/07/14
    In today’s episode, Drs Vikash Oza, MD, and James Treat, MD, delve into the topic, “Does Food Trigger Eczema?” Oza, an associate professor of dermatology and pediatrics and the director of pediatric dermatology at NYU in New York City, and Treat, a professor of clinical pediatrics and dermatology at the Perelman School of Medicine and an affiliate of the Children’s Hospital of Philadelphia, participated in 1 of 3 “Great Debates in Peds Derm” at the 2024 Society for Pediatric Dermatology Annual Meeting in Toronto, Ontario, Canada. The duo shared insights from their debate and pearls for clinicians related to allergy and eczema.
    続きを読む 一部表示
    14 分
  • S2 Ep15: Navigating Artificial Intelligence in Medicine Featuring Albert Yan, MD, FAAP, FAAD
    2024/07/12
    In today’s episode, Albert Yan, MD, FAAP, FAAD, research director at the Children's Hospital of Philadelphia, professor at the Perelman School of Medicine, and executive at Inner Archways LLC, discusses pearls and insights from his lecture presented at the 2024 Society for Pediatric Dermatology Annual Meeting in Toronto, Ontario, Canada. Yan spoke on artificial intelligence and ChatGPT and the balance of positive yet harmful potential of AI chatbots in medicine.
    続きを読む 一部表示
    12 分
  • S2 Ep14: Navigating Systemic Therapies in Atopic Dermatitis
    2024/07/01
    James Song, MD, FAAD, chief medical officer and director of clinical research at Frontier Dermatology in Seattle, Washington, delves into the complexities and advancements in treating atopic dermatitis (AD). Song highlights the challenges of transitioning patients from topical to systemic therapies, emphasizing the need for timely conversations and patient comfort. He discusses the efficacy and rapid response of oral JAK inhibitors compared to biologics, while addressing safety concerns and the necessity for blood monitoring. Song also explores patient-specific factors in treatment choices, the importance of systemic therapy for moderate to severe cases, and the promise of emerging biologics targeting IL-31 and OX40 pathways. This episode is a comprehensive guide for dermatology clinicians navigating the evolving landscape of AD treatments.
    続きを読む 一部表示
    6 分
  • S2 Ep13: Enhancing Vitiligo Care With Nanette Silverberg, MD
    2024/06/25
    In today’s episode, Nanette Silverberg reviews the key highlights from her vitiligo sessions at the 2024 Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference, also known this year as RAVE. Dr. Silverberg is the chief of pediatric dermatology for the Mount Sinai Health System and site director of pediatric and adolescent dermatology at Mount Sinai West and Mount Sinai Beth Israel in New York, as well as the conference chair of the vitiligo portion of RAVE. At the conference, Dr. Silverberg presented “Topical Therapeutics for Vitiligo” and “Excellence in Vitiligo Clinical Practice.” Today, Dr. Silverberg shares the top takeaways from her sessions that clinicians can utilize in their practice.
    続きを読む 一部表示
    11 分
  • S2 Ep12: From Infection to Innovation: The Turn Therapeutics Story
    2024/06/04
    Bradley Burnam, the founder and CEO of Turn Therapeutics, discusses his journey in the pharmaceutical landscape: from his battle with an aggressive antimicrobial resistant infection to the beginnings of Turn, and to the current state of Hexagen technology and its potential in eczema, onychomycosis, and more.
    続きを読む 一部表示
    19 分
  • S2 Ep11: A Reminder of Patient Impact
    2024/05/07
    Brian Kim, MD, had an unexpected attendee at one of his AAD sessions and delves into what's new, what's now, and what's next in atopic dermatitis management.
    続きを読む 一部表示
    6 分